Curis, Inc. (CRIS)
0.4503
-0.02
(-4.07%)
USD |
NASDAQ |
Nov 20, 09:39
Curis Cash from Operations (Quarterly) : -5.749M for Sept. 30, 2026
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -5.749M |
| June 30, 2026 | -9.646M |
| March 31, 2026 | -9.001M |
| December 31, 2025 | -6.371M |
| September 30, 2025 | -5.569M |
| June 30, 2025 | -8.009M |
| March 31, 2025 | -7.252M |
| December 31, 2024 | -9.26M |
| September 30, 2024 | -5.936M |
| June 30, 2024 | -11.14M |
| March 31, 2024 | -13.23M |
| December 31, 2023 | -10.19M |
| September 30, 2023 | -8.181M |
| June 30, 2023 | -7.868M |
| March 31, 2023 | -12.20M |
| December 31, 2022 | -12.27M |
| September 30, 2022 | -13.12M |
| June 30, 2022 | -12.13M |
| March 31, 2022 | -16.82M |
| December 31, 2021 | -8.171M |
| September 30, 2021 | -9.61M |
| June 30, 2021 | -6.659M |
| March 31, 2021 | -13.18M |
| December 31, 2020 | -5.715M |
| September 30, 2020 | -5.877M |
| Date | Value |
|---|---|
| June 30, 2020 | -5.131M |
| March 31, 2020 | -9.016M |
| December 31, 2019 | -5.599M |
| September 30, 2019 | -7.882M |
| June 30, 2019 | -2.12M |
| March 31, 2019 | -10.60M |
| December 31, 2018 | -4.94M |
| September 30, 2018 | -8.223M |
| June 30, 2018 | -6.938M |
| March 31, 2018 | -9.964M |
| December 31, 2017 | -7.505M |
| September 30, 2017 | -16.48M |
| June 30, 2017 | -9.223M |
| March 31, 2017 | -15.15M |
| December 31, 2016 | -9.387M |
| September 30, 2016 | -7.583M |
| June 30, 2016 | -10.85M |
| March 31, 2016 | -7.987M |
| December 31, 2015 | -10.86M |
| September 30, 2015 | -4.482M |
| June 30, 2015 | -6.786M |
| March 31, 2015 | -7.759M |
| December 31, 2014 | -4.692M |
| September 30, 2014 | -2.085M |
| June 30, 2014 | -4.730M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Quarterly) Benchmarks
| Lineage Cell Therapeutics, Inc. | -5.62M |
| Agenus, Inc. | -20.10M |
| Amgen, Inc. | 4.241B |
| Anika Therapeutics, Inc. | 8.377M |
| BioCryst Pharmaceuticals, Inc. | 32.69M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Financing (Quarterly) | 5.69M |
| Free Cash Flow | -30.77M |
| Free Cash Flow Per Share (Quarterly) | -1.376 |
| Free Cash Flow to Equity (Quarterly) | -5.445M |
| Free Cash Flow to Firm (Quarterly) | -5.749M |
| Free Cash Flow Yield | -1.66K% |